Corporate Governance and Disclosure

A premier corporate governance and disclosure practice providing timely, tailored and practical advice to public company clients based on in-depth experience and insight.

Key Contacts

Meet Our Team

Areas of Focus

Expand All Collapse All

Keeping Current: Disclosure and Governance Developments Blog

WilmerHale’s corporate governance and disclosure team provides guidance to public companies and their boards, helping clients navigate the complex landscape of legal and business issues. Our team is well-versed in evolving SEC and stock exchange requirements, emerging governance and disclosure expectations, high-stakes issues such as issuer repurchases, insider trading and executive compensation, and responding to shareholder proposals and other investor communications. This blog offers valuable legal and practical insights on developments and trends impacting public companies. Contributors include members of the firm’s Corporate Practice and our renowned securities enforcement and regulatory practices, who together have served as outside counsel to hundreds of public companies.

Environmental, Social and Corporate Governance (ESG)

The WilmerHale ESG Webinar Series addresses key environmental, social and corporate governance issues facing companies, boards, executives and investors.


  • Public Company Counseling

    We regularly advise public company clients on corporate governance and disclosure matters. These clients include Agios Pharmaceuticals; Akamai Technologies; Analog Devices; CIRCOR International; Danaher Corporation; Discovery; Editas Medicine; Generation Bio; Genpact; Hilton; Huntington Ingalls Industries; Kala Pharmaceuticals; Karyopharm Therapeutics; MKS Instruments; Northrop Grumman; PepsiCo; Revvity (FKA PerkinElmer); PTC Therapeutics; S&P Global; Skyworks Solutions; Solid Biosciences; State Street Corporation; The Walt Disney Company; and Thermo Fisher Scientific.


  • Award Text

    Named a Leading Corporate Practice

    Chambers USA


  • Award Text

    Ranked Band 1 for Securities Regulation: Nationwide

    Chambers USA


  • Award Text

    Ranked Among the Best Law Firms for Corporate Law

    U.S. News – Best Lawyers®


  • Chambers USA Guide – Named our corporate practice among the best in 2012–2024, with sources saying that WilmerHale provides “excellent service and quality advice and representation.” The 2021–2024 editions of Chambers USA also ranked WilmerHale in Washington DC and Boston for Corporate/M&A.
  • Boston Magazine – Recognized 11 WilmerHale corporate lawyers to its 2023 Top Lawyers list.
  • Chambers Global – Recognized 27 WilmerHale lawyers and 31 practice areas in its 20202023 editions.
  • Best Lawyers in America – Recognized 121 WilmerHale lawyers for 2024 naming nine as “Lawyers of the Year.” 
  • U.S. News - Best Lawyers® – Recognized in the 2010–2024 “Best Law Firms” rankings. In the 2024 rankings, our corporate, mergers and acquisitions, and venture capital law practices were ranked in the first tier nationally and in Boston, and our corporate law practice was also ranked in the first tier in Colorado, New York and Washington DC. Our securities/capital markets law practice was ranked in the first tier nationally and in New York and Washington DC. Our technology law practice was also ranked in the first tier nationally and in Boston.
  • The Legal 500 United States – Recognized WilmerHale among top law firms for our work in the area of Corporate Governance in its 2017–2024 editions.
  • Law360 – Named WilmerHale a Technology Practice Group from 2019–2022, an award recognizing the firm’s key role in the significant matters that made headlines and changed the legal landscape within the past year. 
  • Super Lawyers – Our corporate lawyers are consistently recognized as “Super Lawyers” and “Rising Stars” in multiple jurisdictions.

Insights & News


Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.